论文部分内容阅读
一项初步研究的结果表明,长期用干扰素γ-1b和低剂量强的松龙治疗可改善自发性肺纤维化病人的肺功能。奥地利维也纳大学医学院的RolfZiesche认为,干扰素γ-1b的作用有可能改变人们对该疾病的看法。自发性肺纤维化通常在出现症状后的4～5年内导致病人死亡。据Ziesche及其同事介绍,自发性肺纤维化的常规治疗是口服糖(肾上腺)皮质激素。但病人接受
A preliminary study showed that long-term treatment with interferon gamma-1b and low-dose prednisolone can improve lung function in patients with spontaneous pulmonary fibrosis. According to Rolf Ziesche, of the University of Vienna School of Medicine in Austria, the role of interferon gamma-1b may change the way people think of the disease. Spontaneous pulmonary fibrosis usually causes the patient to die within 4 to 5 years of onset of symptoms. According to Ziesche and colleagues, the usual treatment for spontaneous pulmonary fibrosis is the oral administration of sugar (adrenal) corticosteroids. But the patient accepted